VIVXF (Avivagen) Days Payable: 5,134.57 (As of Jul. 2023)


What is Avivagen Days Payable?

Avivagen VIVXF -99.00% Days Payable is 5,134.57 as of Jul. 2023.

Avivagen's average Accounts Payable for the three months ended in Jul. 2023 was $0.73 Mil. Avivagen's Cost of Goods Sold for the three months ended in Jul. 2023 was $0.01 Mil. Hence, Avivagen's Days Payable for the three months ended in Jul. 2023 was 5,134.57.

The historical rank and industry rank for Avivagen's Days Payable or its related term are showing as below:

VIVXF's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.61
* Ranked among companies with meaningful Days Payable only.

Avivagen's Days Payable increased from Jul. 2022 (2,807.02) to Jul. 2023 (5,134.57). It may suggest that Avivagen delayed paying its suppliers.

Avivagen Days Payable Historical Data

* Premium members only.

The historical data trend for Avivagen's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avivagen Days Payable Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 412.61 493.07 315.20 270.62 480.34

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,807.02 248.58 2,454.98 1,870.63 5,134.57

VIVXF vs DMKPQ, MJNE, ACORQ: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Avivagen's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avivagen Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avivagen's Days Payable distribution charts can be found below:

* The bar in red indicates where Avivagen's Days Payable falls into.


Avivagen Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Avivagen's Days Payable for the fiscal year that ended in Oct. 2022 is calculated as

Days Payable (A: Oct. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Oct. 2021 ) + Accounts Payable (A: Oct. 2022 )) / count ) / Cost of Goods Sold (A: Oct. 2022 )*Days in Period
=( (0.372 + 0.665) / 2 ) / 0.394*365
=0.5185 / 0.394*365
=480.34

Avivagen's Days Payable for the quarter that ended in Jul. 2023 is calculated as:

Days Payable (Q: Jul. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Apr. 2023 ) + Accounts Payable (Q: Jul. 2023 )) / count ) / Cost of Goods Sold (Q: Jul. 2023 )*Days in Period
=( (0.865 + 0.598) / 2 ) / 0.013*365 / 4
=0.7315 / 0.013*365 / 4
=5,134.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 5,134.57 mean?
Avivagen (VIVXF) has a Days Payable of 5,134.57 as of Jul. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avivagen and its competitors.
Is Avivagen's Days Payable too high?
Avivagen's current Days Payable is 5,134.57. The Drug Manufacturers industry median Days Payable is 90.61. Avivagen's value of 5,134.57 is 5566.7% above this industry median.
How does Avivagen's Days Payable compare to DMKPQ and MJNE?
Avivagen's Days Payable of 5,134.57 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.61. Avivagen's value of 5,134.57 is 5566.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avivagen's current Days Payable of 5,134.57 is 5566.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avivagen and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avivagen's current Days Payable is 5,134.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avivagen stock overvalued right now?
Avivagen (VIVXF) has a current Days Payable of 5,134.57. The current Days Payable is 5,134.57 and 5566.7% above the Drug Manufacturers industry median of 90.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Avivagen (VIVXF), the current Days Payable is 5,134.57 as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avivagen Business Description

Address 100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc OxC-beta technology is derived from Avivagen discoveries about Beta-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxCbeta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. Avivagen's OxC-beta Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters.